Nitrous Oxide Clinical Trial
Official title:
Colonoscopy Using Nitrous Oxide- A Pilot Study in the USA
Verified date | April 2024 |
Source | University of Arkansas |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Colon cancer is the second most common cancer in men and the third most common cancer in women worldwide. The clinical objectives of administering sedation for GI endoscopy are to relieve patient anxiety and discomfort and to improve the outcome of the examination. Use of N2O could potentially provide an alternate safe and cheap option for patients who do not prefer IV sedation for colonoscopy
Status | Completed |
Enrollment | 200 |
Est. completion date | August 10, 2023 |
Est. primary completion date | August 10, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: Men and women, more than 18 years old Scheduled for a colonoscopy at the Endoscopy unit Exclusion Criteria: - High ASA risk (IV/ >) - History of chronic pain - Allergy to N2O or opioid or BDZ - No consent - Recent head injury with impairment of consciousness or Intracranial / Middle Ear surgery within the previous 6 months with or without residual deficits. - Pneumothorax, air embolism - Decompression sickness or within 48 hours of an underwater dive - Severe emphysema with bullae - Gross abdominal distension with suspicion for bowel obstruction - Intoxication - Maxillofacial injuries (where patient unable to administer the drug using a mouthpiece/mask, or there is the risk of causing further damage to facial wounds and there may also be a significant risk of blood inhalation) - Patients with chronic pulmonary disease for whom an inspired oxygen concentration of more than 28% oxygen might be dangerous - Patients on Methotrexate - Where patients need assistance to hold the mask or mouthpiece. - Retinal surgery within the last three months - Any patient who does not otherwise clinically qualify for standard sedation methods (i.e., those who require general anesthesia) |
Country | Name | City | State |
---|---|---|---|
United States | University of Arkansas for Medical Sciences | Little Rock | Arkansas |
Lead Sponsor | Collaborator |
---|---|
University of Arkansas |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Cecal intubation rates and time of the procedure - total time and recovery | Time required to complete the procedure and reach end of the colon | 1 to 30 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04884893 -
Effect of Nitrous Oxide on EEG
|
Phase 1 | |
Withdrawn |
NCT01622335 -
Effect OF Nitrous Oxide On Acute Pain and Opioid Consumption, and Chronic Pain After Hysterectomy
|
N/A | |
Completed |
NCT04301024 -
Nitrous Oxyde Misuse Among Teenagers Consulting in an Addictology Center Dedicated to Young Drug Users in Montpellier
|
||
Not yet recruiting |
NCT04305990 -
Demand-Driven Method for Gas Delivery in a Dental Setting
|
N/A | |
Not yet recruiting |
NCT06430489 -
Treatment of Suicidal Ideation in the Emergency Department Using Nitrous Oxide
|
Phase 2 | |
Completed |
NCT00482456 -
Homocysteine After Nitrous Oxide Anesthesia
|
Phase 4 | |
Not yet recruiting |
NCT05579288 -
Use of Nitrous Oxide for Pain Alleviation in Women Undergoing Osmotic Dilator Insertion for Dilatation and Evacuation
|
Early Phase 1 | |
Completed |
NCT05435118 -
Use of the Equimolar Mixture of Oxide Nitrous and Oxygen (EMONO) Associated With Audiovisuals in Children
|
N/A |